vs

Side-by-side financial comparison of Albemarle Corporation (ALB) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.4B, roughly 1.2× Albemarle Corporation). Albemarle Corporation runs the higher net margin — -29.0% vs -58.9%, a 29.9% gap on every dollar of revenue. On growth, Albemarle Corporation posted the faster year-over-year revenue change (15.9% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $233.1M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 2.4%).

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

ALB vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.2× larger
IVZ
$1.7B
$1.4B
ALB
Growing faster (revenue YoY)
ALB
ALB
+9.7% gap
ALB
15.9%
6.2%
IVZ
Higher net margin
ALB
ALB
29.9% more per $
ALB
-29.0%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$199.1M more FCF
IVZ
$432.2M
$233.1M
ALB
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
2.4%
ALB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALB
ALB
IVZ
IVZ
Revenue
$1.4B
$1.7B
Net Profit
$-414.2M
$-995.9M
Gross Margin
13.9%
Operating Margin
-15.2%
-86.2%
Net Margin
-29.0%
-58.9%
Revenue YoY
15.9%
6.2%
Net Profit YoY
-650.1%
-575.8%
EPS (diluted)
$-3.88
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALB
ALB
IVZ
IVZ
Q4 25
$1.4B
$1.7B
Q3 25
$1.3B
$1.6B
Q2 25
$1.3B
$1.5B
Q1 25
$1.1B
$1.5B
Q4 24
$1.2B
$1.6B
Q3 24
$1.4B
$1.5B
Q2 24
$1.4B
$1.5B
Q1 24
$1.4B
$1.5B
Net Profit
ALB
ALB
IVZ
IVZ
Q4 25
$-414.2M
$-995.9M
Q3 25
$-160.7M
$356.4M
Q2 25
$22.9M
$197.4M
Q1 25
$41.3M
$171.1M
Q4 24
$75.3M
$209.3M
Q3 24
$-1.1B
$55.0M
Q2 24
$-188.2M
$132.2M
Q1 24
$2.4M
$141.5M
Gross Margin
ALB
ALB
IVZ
IVZ
Q4 25
13.9%
Q3 25
9.0%
Q2 25
14.8%
Q1 25
14.5%
Q4 24
11.2%
Q3 24
-7.7%
Q2 24
-0.7%
Q1 24
2.9%
Operating Margin
ALB
ALB
IVZ
IVZ
Q4 25
-15.2%
-86.2%
Q3 25
-16.6%
16.5%
Q2 25
3.6%
14.1%
Q1 25
1.8%
18.1%
Q4 24
0.4%
19.6%
Q3 24
-81.9%
6.6%
Q2 24
-34.4%
13.9%
Q1 24
-13.2%
14.4%
Net Margin
ALB
ALB
IVZ
IVZ
Q4 25
-29.0%
-58.9%
Q3 25
-12.3%
21.7%
Q2 25
1.7%
13.0%
Q1 25
3.8%
11.2%
Q4 24
6.1%
13.1%
Q3 24
-78.9%
3.6%
Q2 24
-13.2%
8.9%
Q1 24
0.2%
9.6%
EPS (diluted)
ALB
ALB
IVZ
IVZ
Q4 25
$-3.88
$-2.61
Q3 25
$-1.72
$0.66
Q2 25
$-0.16
$-0.03
Q1 25
$0.00
$0.38
Q4 24
$0.29
$0.46
Q3 24
$-9.45
$0.12
Q2 24
$-1.96
$0.29
Q1 24
$-0.08
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALB
ALB
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$3.2B
$1.8B
Stockholders' EquityBook value
$9.5B
$12.2B
Total Assets
$16.4B
$27.1B
Debt / EquityLower = less leverage
0.33×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALB
ALB
IVZ
IVZ
Q4 25
$1.0B
Q3 25
$1.9B
$973.1M
Q2 25
$1.8B
$922.7M
Q1 25
$1.5B
$821.7M
Q4 24
$1.2B
$986.5M
Q3 24
$1.7B
$1.0B
Q2 24
$1.8B
$878.5M
Q1 24
$2.1B
$895.7M
Total Debt
ALB
ALB
IVZ
IVZ
Q4 25
$3.2B
$1.8B
Q3 25
$3.6B
$1.6B
Q2 25
$3.6B
$1.9B
Q1 25
$3.5B
$964.8M
Q4 24
$3.5B
$890.6M
Q3 24
$3.6B
$890.3M
Q2 24
$3.5B
$890.1M
Q1 24
$3.5B
$1.3B
Stockholders' Equity
ALB
ALB
IVZ
IVZ
Q4 25
$9.5B
$12.2B
Q3 25
$10.0B
$14.0B
Q2 25
$10.2B
$13.9B
Q1 25
$10.0B
$14.7B
Q4 24
$10.0B
$14.6B
Q3 24
$10.2B
$14.8B
Q2 24
$11.2B
$14.6B
Q1 24
$11.5B
$14.6B
Total Assets
ALB
ALB
IVZ
IVZ
Q4 25
$16.4B
$27.1B
Q3 25
$17.1B
$28.4B
Q2 25
$17.3B
$28.5B
Q1 25
$17.0B
$28.1B
Q4 24
$16.6B
$27.0B
Q3 24
$17.5B
$27.5B
Q2 24
$18.4B
$27.2B
Q1 24
$19.0B
$28.1B
Debt / Equity
ALB
ALB
IVZ
IVZ
Q4 25
0.33×
0.15×
Q3 25
0.36×
0.12×
Q2 25
0.35×
0.14×
Q1 25
0.35×
0.07×
Q4 24
0.35×
0.06×
Q3 24
0.35×
0.06×
Q2 24
0.31×
0.06×
Q1 24
0.31×
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALB
ALB
IVZ
IVZ
Operating Cash FlowLast quarter
$388.5M
$455.8M
Free Cash FlowOCF − Capex
$233.1M
$432.2M
FCF MarginFCF / Revenue
16.3%
25.5%
Capex IntensityCapex / Revenue
10.9%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$692.5M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALB
ALB
IVZ
IVZ
Q4 25
$388.5M
$455.8M
Q3 25
$355.6M
$606.2M
Q2 25
$-7.2M
$547.9M
Q1 25
$545.4M
$-84.6M
Q4 24
$674.0K
$316.9M
Q3 24
$240.5M
$438.4M
Q2 24
$362.9M
$489.1M
Q1 24
$98.0M
$-54.4M
Free Cash Flow
ALB
ALB
IVZ
IVZ
Q4 25
$233.1M
$432.2M
Q3 25
$223.4M
$586.4M
Q2 25
$-126.8M
$530.4M
Q1 25
$362.8M
$-108.0M
Q4 24
$-355.1M
$309.9M
Q3 24
$-62.6M
$410.0M
Q2 24
$-84.7M
$462.4M
Q1 24
$-481.4M
$-75.4M
FCF Margin
ALB
ALB
IVZ
IVZ
Q4 25
16.3%
25.5%
Q3 25
17.1%
35.7%
Q2 25
-9.5%
35.0%
Q1 25
33.7%
-7.1%
Q4 24
-28.8%
19.5%
Q3 24
-4.6%
27.1%
Q2 24
-5.9%
31.2%
Q1 24
-35.4%
-5.1%
Capex Intensity
ALB
ALB
IVZ
IVZ
Q4 25
10.9%
1.4%
Q3 25
10.1%
1.2%
Q2 25
9.0%
1.2%
Q1 25
17.0%
1.5%
Q4 24
28.9%
0.4%
Q3 24
22.4%
1.9%
Q2 24
31.3%
1.8%
Q1 24
42.6%
1.4%
Cash Conversion
ALB
ALB
IVZ
IVZ
Q4 25
Q3 25
1.70×
Q2 25
-0.31×
2.78×
Q1 25
13.19×
-0.49×
Q4 24
0.01×
1.51×
Q3 24
7.97×
Q2 24
3.70×
Q1 24
40.01×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALB
ALB

Energy Storage$759.1M53%
Specialties$348.9M24%
Ketjen$320.1M22%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons